Table 2 Summary of CRISPR/Cas9-induced site-specific insertion with ssODN through HDR.
Injected components | No. of tested blastocysts | HDR blastocysts (% of tested) | Precise HDR (% of tested) |
---|---|---|---|
Cas9 mRNA + R1 sgRNA + ssODN (80 ng/μL) | 23 | 3 (13.04) | 2 (8.70) |
Cas9 mRNA + R1 sgRNA + ssODN (10 ng/μL) | 20 | 0 | 0 |
Cas9 mRNA + F2 sgRNA + ssODN (80 ng/μL) | 19 | 0 | 0 |